Nxera Pharma Co., Ltd.
OTC: SOLTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christopher Cargill
- Employees
- 387
- Headquarters
- Tokyo, Japan
- IPO year
- 2013
- Market cap
- $584.3M
- Website
- https://soseiheptares.com
Loading SOLTF…
Loading profile data…Frequently asked questions about SOLTF
What does Nxera Pharma Co., Ltd. (SOLTF) do?
Nxera Pharma Co., Ltd. is a biopharmaceutical enterprise specializing in the development and global commercialization of pharmaceutical products. Operating across Japan, Switzerland, the United States, Bermuda, and the United Kingdom, the company provides a range of established treatments. Its current commercialized offerings include Ultibro/Bre...
Where does SOLTF trade?
Nxera Pharma Co., Ltd. (SOLTF) trades on the Other OTC.
What sector is SOLTF in?
Nxera Pharma Co., Ltd. (SOLTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nxera Pharma Co., Ltd.?
Christopher Cargill is the chief executive officer of Nxera Pharma Co., Ltd. (SOLTF).
Where is Nxera Pharma Co., Ltd. headquartered?
Nxera Pharma Co., Ltd. is headquartered in Japan.
Does SOLTF pay a dividend?
Nxera Pharma Co., Ltd. (SOLTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SOLTF go public?
Nxera Pharma Co., Ltd. (SOLTF) completed its initial public offering in 2013.